Left ventricular assist devices and bleeding

Adding insult to injury

Daniel J. Goldstein, Robert B. Beauford

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

Bleeding is the most common postoperative complication after implantation of left ventricular assist devices, necessitating reoperation in up to 60% of recipients. The implications of massive blood transfusions are great and include infection, pulmonary insufficiency, increased costs, right heart failure, allosensitization, and viral transmission, some of which can prove fatal or preclude transplantation. Preoperative evaluation and preparation are essential, intraoperative hemostasis is imperative, and "shotgun" product replacement should be avoided. Adherence to protocols emphasizing "hemostatic readiness" could reduce the incidence of bleeding complications that pervade left ventricular assist device therapy and potentially improve current successes in bridging to transplantation.

Original languageEnglish (US)
JournalAnnals of Thoracic Surgery
Volume75
Issue number6 SUPPL.
DOIs
StatePublished - Jun 1 2003
Externally publishedYes

Fingerprint

Heart-Assist Devices
Transplantation
Hemorrhage
Wounds and Injuries
Firearms
Hemostatics
Hemostasis
Reoperation
Blood Transfusion
Heart Failure
Costs and Cost Analysis
Lung
Incidence
Infection
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Left ventricular assist devices and bleeding : Adding insult to injury. / Goldstein, Daniel J.; Beauford, Robert B.

In: Annals of Thoracic Surgery, Vol. 75, No. 6 SUPPL., 01.06.2003.

Research output: Contribution to journalArticle

@article{971ff1d6b58344bc8e1e1cc435cd2890,
title = "Left ventricular assist devices and bleeding: Adding insult to injury",
abstract = "Bleeding is the most common postoperative complication after implantation of left ventricular assist devices, necessitating reoperation in up to 60{\%} of recipients. The implications of massive blood transfusions are great and include infection, pulmonary insufficiency, increased costs, right heart failure, allosensitization, and viral transmission, some of which can prove fatal or preclude transplantation. Preoperative evaluation and preparation are essential, intraoperative hemostasis is imperative, and {"}shotgun{"} product replacement should be avoided. Adherence to protocols emphasizing {"}hemostatic readiness{"} could reduce the incidence of bleeding complications that pervade left ventricular assist device therapy and potentially improve current successes in bridging to transplantation.",
author = "Goldstein, {Daniel J.} and Beauford, {Robert B.}",
year = "2003",
month = "6",
day = "1",
doi = "10.1016/S0003-4975(03)00478-8",
language = "English (US)",
volume = "75",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "6 SUPPL.",

}

TY - JOUR

T1 - Left ventricular assist devices and bleeding

T2 - Adding insult to injury

AU - Goldstein, Daniel J.

AU - Beauford, Robert B.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Bleeding is the most common postoperative complication after implantation of left ventricular assist devices, necessitating reoperation in up to 60% of recipients. The implications of massive blood transfusions are great and include infection, pulmonary insufficiency, increased costs, right heart failure, allosensitization, and viral transmission, some of which can prove fatal or preclude transplantation. Preoperative evaluation and preparation are essential, intraoperative hemostasis is imperative, and "shotgun" product replacement should be avoided. Adherence to protocols emphasizing "hemostatic readiness" could reduce the incidence of bleeding complications that pervade left ventricular assist device therapy and potentially improve current successes in bridging to transplantation.

AB - Bleeding is the most common postoperative complication after implantation of left ventricular assist devices, necessitating reoperation in up to 60% of recipients. The implications of massive blood transfusions are great and include infection, pulmonary insufficiency, increased costs, right heart failure, allosensitization, and viral transmission, some of which can prove fatal or preclude transplantation. Preoperative evaluation and preparation are essential, intraoperative hemostasis is imperative, and "shotgun" product replacement should be avoided. Adherence to protocols emphasizing "hemostatic readiness" could reduce the incidence of bleeding complications that pervade left ventricular assist device therapy and potentially improve current successes in bridging to transplantation.

UR - http://www.scopus.com/inward/record.url?scp=0037636659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037636659&partnerID=8YFLogxK

U2 - 10.1016/S0003-4975(03)00478-8

DO - 10.1016/S0003-4975(03)00478-8

M3 - Article

VL - 75

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 6 SUPPL.

ER -